UroGen Pharma Ltd News

UroGen Pharma Analyst Ratings

BenzingaJul 1 18:57

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $60 Price Target

BenzingaJul 1 18:57

Ladenburg Thalmann Maintains Buy on UroGen Pharma, Raises Price Target to $53.5

BenzingaJun 15 02:42

Ladenburg Thalmann Raises Price Target on UroGen Pharma to $53.50 From $48, Maintains Buy Rating

MT NewswiresJun 14 18:55

UroGen Pharma Analyst Ratings

BenzingaJun 14 18:22

Oppenheimer: UroGen Pharma (URGN.US) rating was maintained, and the target price was adjusted from superior to superior to market, and the target price was adjusted from $34.00 to $32.00.

Zhitong FinanceMay 14 20:32

Oppenheimer Maintains Outperform on UroGen Pharma, Lowers Price Target to $32

BenzingaMay 14 20:30

UroGen Pharma Analyst Ratings

BenzingaMay 14 18:25

HC Wainwright & Co. : The UroGen Pharma (URGN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $54.00.

Zhitong FinanceMay 6 18:20

UroGen Pharma Analyst Ratings

BenzingaMay 6 18:20

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $54 Price Target

BenzingaMay 6 18:20

HC Wainwright & Co. : The UroGen Pharma (URGN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $54.00.

Zhitong FinanceApr 18 18:31

UroGen Pharma Analyst Ratings

BenzingaApr 18 18:25

UroGen Pharma Analyst Ratings

BenzingaApr 4 18:35

UroGen Pharma Analyst Ratings

BenzingaMar 18 18:55

UroGen Pharma Analyst Ratings

BenzingaMar 15 20:40

Oppenheimer Adjusts UroGen Pharma Price Target to $35 From $32, Maintains Outperform Rating

MT NewswiresJan 24 22:03

UroGen Pharma Analyst Ratings

BenzingaNov 16, 2023 02:22

Oppenheimer Adjusts UroGen Pharma Price Target to $32 From $33, Maintains Outperform Rating

MT NewswiresNov 15, 2023 22:45

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $54 Price Target

BenzingaOct 4, 2023 18:16